Jasper Therapeutics
JSPR
JSPR
46 hedge funds and large institutions have $120M invested in Jasper Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
29% less capital invested
Capital invested by funds: $169M → $120M (-$48.8M)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
46
Holding in Top 10
2
Calls
$114K
Puts
$34K
Top Buyers
| 1 | +$3.93M | |
| 2 | +$1.08M | |
| 3 | +$980K | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$671K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$645K |
Top Sellers
| 1 | -$7.24M | |
| 2 | -$4.22M | |
| 3 | -$3.54M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.62M |
| 5 |
Jane Street
New York
|
-$382K |